These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22006752)

  • 1. Patients with advanced cholangiocarcinoma benefit from chemotherapy if they are fit to receive it: single center experience.
    Kose F; Abali H; Sezer A; Ali Besen A; Taner Sumbul A; Karadeniz C; Disel U; Ozyilkan U
    J BUON; 2011; 16(3):469-72. PubMed ID: 22006752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic arterial infusion of mitomycin C with degradable starch microspheres for unresectable intrahepatic cholangiocarcinoma.
    Shitara K; Ikami I; Munakata M; Muto O; Sakata Y
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):241-6. PubMed ID: 18222071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice.
    Fuks D; Bartoli E; Delcenserie R; Yzet T; Celice P; Sabbagh C; Chatelain D; Joly JP; Cheron N; Dupas JL; Regimbeau JM
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1745-52. PubMed ID: 19780885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
    Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of pharmacokinetic modulation chemotherapy (PMC) using oral UFT and venous 5-FU infusion as adjuvant chemotherapy for intrahepatic cholangiocellular carcinoma].
    Yokoo H; Kamiyama T; Nakagawa T; Nakanishi K; Tahara M; Fukumori D; Kamachi H; Matsushita M; Todo S
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2400-3. PubMed ID: 20037436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective treatment of advanced cholangiocarcinoma by hepatic arterial infusion chemotherapy combination with sorafenib: one case report from China.
    Qun W; Tao Y
    Hepatogastroenterology; 2010; 57(99-100):426-9. PubMed ID: 20698202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
    Kahaleh M; Mishra R; Shami VM; Northup PG; Berg CL; Bashlor P; Jones P; Ellen K; Weiss GR; Brenin CM; Kurth BE; Rich TA; Adams RB; Yeaton P
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):290-7. PubMed ID: 18255347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy for unresectable cholangiocarcinoma: contribution of single operator cholangioscopy for targeted treatment.
    Talreja JP; DeGaetani M; Sauer BG; Kahaleh M
    Photochem Photobiol Sci; 2011 Jul; 10(7):1233-8. PubMed ID: 21512706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical procedure and prognosis of hilar cholangiocarcinoma.
    Yi B; Zhang BH; Zhang YJ; Jiang XQ; Zhang BH; Yu WL; Chen QB; Wu MC
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):453-7. PubMed ID: 15313688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management of intrahepatic cholangiocarcinoma--a population-based study.
    Tan JC; Coburn NG; Baxter NN; Kiss A; Law CH
    Ann Surg Oncol; 2008 Feb; 15(2):600-8. PubMed ID: 17987347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial chemotherapy and conformal radiation abolish malignant biliary obstruction.
    Guan YS; Qing He ; Ping Li ; Fu YC; Zhao SW
    Integr Cancer Ther; 2008 Mar; 7(1):51-3. PubMed ID: 18292595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.
    Li SQ; Liang LJ; Hua YP; Peng BG; He Q; Lu MD; Chen D
    Chin Med J (Engl); 2009 Oct; 122(19):2286-91. PubMed ID: 20079127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years.
    Sano T; Shimada K; Sakamoto Y; Esaki M; Kosuge T
    J Hepatobiliary Pancreat Surg; 2007; 14(5):455-62. PubMed ID: 17909713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.
    Kaiser GM; Frühauf NR; Lang H; Sauerwein W; Sotiropoulos GC; Zöpf T; Grabellus F; Wittig A; Oldhafer KJ; Malagó M; Broelsch CE
    Hepatogastroenterology; 2008; 55(88):1951-4. PubMed ID: 19260456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
    Furuse J; Okusaka T; Funakoshi A; Yamao K; Nagase M; Ishii H; Nakachi K; Ueno H; Ikeda M; Morizane C; Horikawa Y; Mizuno N
    Jpn J Clin Oncol; 2006 Sep; 36(9):552-6. PubMed ID: 16887837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
    Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H
    Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative surgical bypass versus percutaneous transhepatic biliary drainage on unresectable hilar cholangiocarcinoma.
    Wongkonkitsin N; Phugkhem A; Jenwitheesuk K; Saeseow OT; Bhudhisawasdi V
    J Med Assoc Thai; 2006 Nov; 89(11):1890-5. PubMed ID: 17205870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
    Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
    Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.